Escitalopram is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for the management of major depressive disorder and generalized anxiety disorder by modulating serotonin activity in… Read more







![Chemical structure of (S)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-benzonitrile Di-p-toluoyl-D-tartrate Salt (2:1)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F128173-53-5-S-4-4-Dimethylamino-1-4-fluorophenyl-1-hydroxybutyl-3-hydroxymethyl-benzonitrile-Di-p-toluoyl-D-tartrate-Salt-21.png&w=3840&q=75)












![Chemical structure of 4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F103146-25-4-4-4-Dimethylamino-1-4-fluorophenyl-1-hydroxybutyl-3-hydroxymethylbenzonitrile.png&w=3840&q=75)
![Chemical structure of 4-[4-(Dimethylamino)-1-oxobutyl]-3-(hydroxymethyl)benzonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1433278-33-1-4-4-Dimethylamino-1-oxobutyl-3-hydroxymethylbenzonitrile.png&w=3840&q=75)
















Escitalopram is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for the management of major depressive disorder and generalized anxiety disorder by modulating serotonin activity in the brain. To support pharmaceutical quality assurance and regulatory compliance, this category provides a comprehensive range of reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These high-quality materials are essential for rigorous analytical testing and method validation, enabling accurate impurity profiling and the identification of potential degradation products in finished formulations. Laboratories frequently utilize stable isotope labelled variants as internal standards for mass spectrometry-based assays, ensuring precise quantification and reproducibility. By incorporating these well-characterized reference compounds into routine quality control protocols, researchers can verify the stability, efficacy, and safety of pharmaceutical products throughout their lifecycle, facilitating adherence to stringent international pharmacopoeia standards.